Author

Shizhe Li

Observed name: Shu Liu

Institutions: Central South University, Chinese Academy of Sciences, Xiangya Hospital Central South University

Observed institutions: Guangdong University of Technology, Central South University, Jilin University, Chinese Academy of Sciences, Changchun Normal University, Jilin Engineering Normal University, First Hospital of China Medical University, Xiangya Hospital Central South University

ORCID: 0000-0003-1382-0289

Observed ORCID: 0000-0003-1382-0289

OpenAlex ID: A5101944166

Chemical profiling of Wu-tou decoction by UPLC–Q-TOF-MS

2013 · Yao Qi, Shizhe Li, et al. · Talanta · 113

Systematically characterize the absorbed effective substances of Wutou Decoction and their metabolic pathways in rat plasma using UHPLC-Q-TOF-MS combined with a target network pharmacological analysis

2017 · Tengfei Xu, Shizhe Li, et al. · Journal of Pharmaceutical and Biomedical Analysis · 81

Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS

2019 · Mengying Wei, Zhongying Liu, et al. · Food & Function · 46

Chemical profiling of Fufang-Xialian-Capsule by UHPLC-Q-TOF-MS and its antioxidant activity evaluated by in vitro method

2017 · Shizhe Li, Shu Liu, et al. · Journal of Pharmaceutical and Biomedical Analysis · 35

Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood

2018 · Shizhe Li, Tengfei Xu, et al. · Royal Society Open Science · 12

Progress in synthesis of imidazo-, benzoimidazo- and phenanthroimidazophenanthridine skeletons

2025 · Yeming Wang, Chaoqun Zhang, et al. · Tetrahedron · 1

Exploring the pharmacological and adverse reaction mechanism of a drug by network pharmacology strategy: Using colchicine to treat Behcet syndrome as an example

2023 · Shizhe Li, Lei Wang, et al. · Medicine · 1

Immunometabolic and epigenetic reprogramming in inflammatory bowel disease: from mechanistic circuits to therapeutic targeting

2026 · Yi Han, Jun Yi, et al. · Biomarker Research

Additional file 1 of Assessing pangolin scale morphology and genetic identifiability following varied processing treatments

2026 · Max De Yuan Khoo, Darren Yeo, et al. · Figshare

Additional file 2 of Assessing pangolin scale morphology and genetic identifiability following varied processing treatments

2026 · Max De Yuan Khoo, Darren Yeo, et al. · Figshare

Assessing pangolin scale morphology and genetic identifiability following varied processing treatments

2026 · Max De Yuan Khoo, Darren Yeo, et al. · Figshare

The role of gut microbiome in colorectal cancer development: a comprehensive analysis based on metabolomics and immunomodulatory mechanisms

2025 · Yichi Xu, Bo Wen, et al. · Frontiers in Oncology

Works count: 12

Citation count: 289

H-index: 5

I10-index: 5